TRANSLATE BIO INC's ticker is TBIO and the CUSIP is 89374L104. A total of 75 filers reported holding TRANSLATE BIO INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $2,490,000 | +0.6% | 90,400 | -39.8% | 0.00% | – |
| Q1 2021 | $2,476,000 | -57.7% | 150,187 | -52.7% | 0.00% | -100.0% |
| Q4 2020 | $5,857,000 | +53.8% | 317,820 | +13.6% | 0.00% | 0.0% |
| Q3 2020 | $3,809,000 | -54.9% | 279,861 | -40.6% | 0.00% | -66.7% |
| Q2 2020 | $8,448,000 | +1798.4% | 471,424 | +955.7% | 0.00% | – |
| Q1 2020 | $445,000 | – | 44,653 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Advisors, Inc. | 2,656,517 | $48,960,000 | 10.98% |
| Copernicus Capital Management, LLC | 12,091 | $223,000 | 3.48% |
| FRAZIER MANAGEMENT LLC | 2,182,789 | $40,229,000 | 3.10% |
| Baupost Group | 18,044,239 | $326,236,000 | 3.01% |
| DAFNA Capital Management LLC | 225,393 | $4,154,000 | 1.24% |
| RTW INVESTMENTS, LP | 2,978,427 | $54,892,000 | 0.92% |
| MARATHON CAPITAL MANAGEMENT | 143,275 | $2,640,000 | 0.78% |
| Bain Capital Public Equity Management II, LLC | 627,387 | $11,563,000 | 0.59% |
| Artal Group S.A. | 1,200,000 | $22,116,000 | 0.48% |
| Birchview Capital, LP | 30,000 | $553,000 | 0.32% |